Anthem Biosciences’ Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CRDMO firm provides integrated drug development and manufacturing services across advanced technology platforms and modalities.
Recent Posts
- [Latest] Global Low-carbon Methanol Market Size/Share Worth USD 27.7 Billion by 2034 at a 34.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Bitcoin, Robinhood, Coinbase Surged 30% To 100% In Q2: What’s Next?
- ReserveOne to go public via merger, create crypto reserve
- Bitcoin news update: BTC range tightening hints at price break to new highs
- Japanese company moves to align CEO with Bitcoin strategy, full salary goes to BTC